This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Support our work
Our impact
Our work would simply not be possible without the support of generous individuals and organisations. Your donation will directly contribute to world-leading research that improves the lives of people living with eye disease.
Hope in sight
Transformational philanthropy
Connie Kimberley and Craig Kimberley AM
CERA is incredibly grateful for the support of the Kimberley Family Foundation, which has donated $1 million to glaucoma research.
Connie Kimberley and Craig Kimberley AM
CERA is incredibly grateful for the support of the Kimberley Family Foundation, which has donated $1 million to glaucoma research.
Supporter stories
Judith and Brian Gilpin
Judith and Brian are valued supporters of CERA’s vision research. They hope they can help future generations with eye conditions such as glaucoma and age-related macular degeneration.
Dorothea Carmichael
“CERA’s vision is close to my heart. That’s why I chose donations instead of presents for my 90th birthday,” says Dorothea.
Judith and Brian Gilpin
Judith and Brian are valued supporters of CERA’s vision research. They hope they can help future generations with eye conditions such as glaucoma and age-related macular degeneration.
Dorothea Carmichael
“CERA’s vision is close to my heart. That’s why I chose donations instead of presents for my 90th birthday,” says Dorothea.
Patient stories
Patricia Keith
Patricia, a retired ophthalmic nurse, took part in a world-first trial at CERA for a new treatment for age-related macular degeneration (AMD).
Desmond De Klerk
Desmond took part in a clinical trial at CERA, playing an important role in the future of glaucoma treatment.
David Knight
David first became aware and interested in ageing eye disease when his mother became blind with age-related macular degeneration (AMD).
Patricia Keith
Patricia, a retired ophthalmic nurse, took part in a world-first trial at CERA for a new treatment for age-related macular degeneration (AMD).
Desmond De Klerk
Desmond took part in a clinical trial at CERA, playing an important role in the future of glaucoma treatment.
David Knight
David first became aware and interested in ageing eye disease when his mother became blind with age-related macular degeneration (AMD).
Researcher stories
‘Blue sky’ breakthroughs
Dr Raymond Wong explains how philanthropic funding has made all the difference to his innovative stem cell research.
Common pathways from rare diseases
Dr Isabel Lopez Sanchez is building a global reputation in mitochondrial research, particularly in a disease called Leber’s Hereditary Optic Neuropathy (LHON).
Repairing the eye’s ‘window’
Since completing his PhD on how to engineer corneal tissue in 2015, Dr Karl Brown continues to work with the CERA team to make laboratory-grown corneal transplants a reality.
‘Blue sky’ breakthroughs
Dr Raymond Wong explains how philanthropic funding has made all the difference to his innovative stem cell research.
Common pathways from rare diseases
Dr Isabel Lopez Sanchez is building a global reputation in mitochondrial research, particularly in a disease called Leber’s Hereditary Optic Neuropathy (LHON).
Repairing the eye’s ‘window’
Since completing his PhD on how to engineer corneal tissue in 2015, Dr Karl Brown continues to work with the CERA team to make laboratory-grown corneal transplants a reality.